
Akt3 degrader 1
CAS No. 2836342-69-7
Akt3 degrader 1 ( —— )
产品货号. M36618 CAS No. 2836342-69-7
Akt3 degrader 1 (化合物 12l) 是一种选择性的 Akt3 降解剂,能克服 Osimertinib (HY-15772) 诱导的 H1975OR NSCLC 细胞的抗性。Akt3 degrader 1 还具有抗增殖活性,能显著抑制小鼠体内肿瘤的生长。Akt3 degrader 1 可用于耐药性非小细胞肺癌的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥2519 | 有现货 |
![]() ![]() |
5MG | ¥3900 | 有现货 |
![]() ![]() |
10MG | ¥5588 | 有现货 |
![]() ![]() |
25MG | ¥8446 | 有现货 |
![]() ![]() |
50MG | ¥11652 | 有现货 |
![]() ![]() |
100MG | ¥14994 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Akt3 degrader 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Akt3 degrader 1 (化合物 12l) 是一种选择性的 Akt3 降解剂,能克服 Osimertinib (HY-15772) 诱导的 H1975OR NSCLC 细胞的抗性。Akt3 degrader 1 还具有抗增殖活性,能显著抑制小鼠体内肿瘤的生长。Akt3 degrader 1 可用于耐药性非小细胞肺癌的研究。
-
产品描述Akt3 degrader 1 (compound 12l) is a selective Akt3 degrader that overcomes Osimertinib (HY-15772)-induced resistance in H1975OR NSCLC cells. Akt3 degrader 1 also has anti-proliferative activity and significantly inhibits tumour growth in mice. Akt3 degrader 1 can be used in the study of drug-resistant non-small cell lung cancer.
-
体外实验Akt3 degrader 1 (0.001-100 μM; 24 h) shows antiproliferative effects on H1975OR cells with an IC50 of 0.972 μM.Akt3 degrader 1 (1.6, 8, 40, 200, 1000 nM; 24 h) induces degradation of Akt3 through the ubiquitin proteasome-mediated proteolysis process in NSCLC cell lines.Akt3 degrader 1 (10, 100 nM) selectively and dose-dependently degrades exogenous PH domain-only Akt3 protein but not the Akt3 del PH mutant in H1975OR cells.Akt3 degrader 1 overcomes osimertinib-induced resistance in H1975OR NSCLC cells via disrupting the noncatalytic functions of Akt3.Cell Proliferation Assay Cell Line:H1975OR cells Concentration:0.001-100 μM Incubation Time:24 h Result:Inhibited growth of H1975OR cells with an IC50 of 0.972 μM.Western Blot Analysis Cell Line:A549, HCC827, H1975, H1975OR, PC9, H1299, and H460 cells Concentration:1.6, 8, 40, 200, 1000 nM Incubation Time:24 h Result:Selectively induced Akt3 degradation in all of these cell lines in a dose-dependent manner, whereas had minimal influence on Akt1 and Akt2 protein levels.
-
体内实验Akt3 degrader 1 (10, 20 mg/kg; i.p.; every 3 days for 5 weeks) induces significant tumor growth inhibition (TGI) with an approximately TGI value of 75% in mice.Animal Model:NOD-SCID-IL2Rg-/-(NSI) mice (H1975OR xenograft model).Dosage:10, 20 mg/kg Administration:Intraperitoneal administration; every 3 days for 5 weeks Result:Inhibited tumor growth without causing obvious body weight loss or other signs of toxicity.
-
同义词——
-
通路Cytoskeleton/Cell Adhesion Molecules
-
靶点Akt
-
受体Akt
-
研究领域——
-
适应症——
化学信息
-
CAS Number2836342-69-7
-
分子量885.19
-
分子式C53H72N8O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1C=C(C=2C=NC(=NC2N1C=3C=CC=C(C3)NC(=O)C4CC4)NC5=CC=C(C=C5OC)N6CCN(CC6)CCCCCCCCCCCCNC(=O)CC78CC9CC(CC(C9)C7)C8)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Xu F, et al. Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells. J Med Chem. 2022 Oct 27;65(20):14032-14048. ?
产品手册




关联产品
-
AKT-IN-6
AKT-IN-6 (Example 13) 是一种有效的 AKT 抑制剂。AKT-IN-6抑制 Akt1、Akt2 和 Akt3, IC50s 分别 < 500nM,来自专利WO201305615A1。
-
CCT128930
CCT128930 是一种有效的、选择性的、ATP 竞争性 AKT 抑制剂,IC50 为 6 nM (AKT2)。
-
Pachymic acid
Pachymic Acid 是一种天然产物,可抑制 Akt 和 ERK 信号通路。Pachymic Acid (PA) 在体外表现出抗肿瘤作用,并诱导 NCI-H23 和 NCI-H460 肺癌细胞 G2/M 期阻滞和凋亡。